Thomas Pålsson
Financieel Directeur/CFO bij CIRCHEM AB
Profiel
Thomas Pålsson is currently the Chief Financial Officer at Toleranzia AB, Monivent AB, Stayble Therapeutics AB, CirChem AB, and is also the Owner & Procurator at Besattningen 1 Kommanditbolag.
He previously held the position of Chief Financial Officer at Arexis AB and Integrum AB.
Mr. Pålsson received a graduate degree and an MBA from Handelshögskolan i Göteborg.
Actieve functies van Thomas Pålsson
| Bedrijven | Functie | Begin |
|---|---|---|
| CIRCHEM AB | Financieel Directeur/CFO | 01-09-2020 |
| STAYBLE THERAPEUTICS AB | Financieel Directeur/CFO | 01-01-2018 |
| MONIVENT AB | Financieel Directeur/CFO | - |
| TOLERANZIA AB | Financieel Directeur/CFO | 30-10-2023 |
| Fullriggaren Konsult AB | Financieel Directeur/CFO | - |
| Besattningen 1 Kommanditbolag | Corporate Officer/Principal | - |
Eerdere bekende functies van Thomas Pålsson
| Bedrijven | Functie | Einde |
|---|---|---|
| INTEGRUM AB | Financieel Directeur/CFO | 09-10-2019 |
Arexis AB
 Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Financieel Directeur/CFO | - |
Opleiding van Thomas Pålsson
| Handelshögskolan i Göteborg | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| INTEGRUM AB | Health Technology |
| CIRCHEM AB | Process Industries |
| STAYBLE THERAPEUTICS AB | Health Technology |
| MONIVENT AB | Health Technology |
| TOLERANZIA AB | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Fullriggaren Konsult AB | |
| Besattningen 1 Kommanditbolag | |
Arexis AB
Arexis AB Pharmaceuticals: MajorHealth Technology Arexis AB develops and manufactures pharmaceutical products. Its products are used for molecular dissection of metabolic and inflammatory diseases. The company was founded in 1999 and is headquartered in Goteborg, Sweden. | Health Technology |
